Odds of COVID-19 Mortality Lower for Women Receiving HRT
Receiving HRT within 6 months of recorded COVID-19 diagnosis linked to reduction in mortality risk.
Hormone Replacement Therapy
Hormone Replacement Therapy in Menopause Linked to Asthma Development
Airway symptoms may develop in menopausal women with no prior history of asthma following the initiation of hormone replacement therapy.
Cardiovascular Risk Among Transgender Persons Initiating Gender-Affirming Hormone Therapy
Transgender persons who present for gender-affirming hormone therapy may be at an elevated cardiovascular risk.
Nurse Practitioners Advocate Access to Hormone Therapy for Transgender Patients
Study finds nurse practitioners should advocate for gender-affirming hormone therapy (GAHT) to alleviate depressive symptoms in transgender patients.
Antibiotics May Reduce Efficacy of Hormonal Contraceptives
Unintended pregnancies were reported 7 times more often by patients who took antibiotics compared with those who took control medicines.
COVID-19 May Increase VTE Risk in Pregnant Women, Individuals Taking Estrogen Therapy
Several questions remain regarding the effect of COVID-19 infection and hypercoagulation in the management of patients taking oral contraceptives, estrogen therapy, and patients who are pregnant.
Menopausal Hormonal Therapy May Cut UTI Risk
New study is the first focused analysis of bacterial diversity in the urogenital tract of postmenopausal women, according to investigators.
Hormone Therapies Tied to Brain Changes in Menopausal Women
In recently menopausal women using hormone treatment, circulating levels of pituitary-ovarian hormones are associated with changes in white matter hyperintensities.
How Does Gender-Affirming Hormone Treatment Affect the Metabolic Profile in Transgender Individuals?
Cross-sex hormone therapy may have a negative effect on lipid profile and glucose levels in transgender men but not in transgender women.
Elagolix Reduces Menstrual Bleeding in Women With Uterine Fibroids
Researchers sought to assess the efficacy and safety of elagolix with add-back hormone therapy in the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
- Loading...
Loading...
Next post in Ob/Gyn Information Center
Loading... 
Loading...